🚀 mRNA therapeutics demand specialized bioanalysis. See how ResolveMass solved LNP interference & complex matrix challenges for IND success. Read more: resolvemass.ca/bioanalytical… #mRNATherapeutics #AnalyticalTesting

Ascertaining whether all cancerous tissue has been removed post-surgery can be challenging. Current follow-up methods, including imaging scans and clinical examinations, may not detect minimal residual disease until symptoms appear or tumors become visible. Here’s where blood-based monitoring can offer a less invasive way to track a patient’s condition and guide post-operative care. Read on to find out how a highly sensitive blood test that detects tumor-related viral DNA could help clinicians assess the success of cancer surgery ➡️ Viral DNA blood test could reveal cancer surgery success - Bioanalysis Zone (hubs.ly/Q04ldBmd0)

📢 Voting closes soon! Support your favorite bioanalysis rising star before time runs out! hubs.ly/Q04hVgYs0 #BRSA2026

Principal Scientist: PKDM-BA (Small molecule bioanalysis group lead) Amgen - Hyderābād, India Read the full job description and apply⤵️ jobrxiv.org/job/principal-sc…

📢 New Special Issue Open for Submissions: Advances in the Mass Spectrometry of Chemical and Biological Samples, 2nd Edition ✏️ Guest editor Dr. Alina Florina Serb 🔗 Issue: brnw.ch/21x3kLt 📌 #MassSpectrometry #AnalyticalChem #Bioanalysis #MSResearch #LabScience #ChemX

A new article from a team at @MIT examines why current machine learning approaches consistently underperform in decoding small molecule structures from mass spectrometry data. Published in Nature Metabolism, the article identified three key failures >>> Why machine learning still can't crack small molecule structures - Bioanalysis Zone (hubs.ly/Q04l4Yjs0)

Will Dakshat Trivedi win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hV42J0 #BRSA2026

Meet with Jenny Pedersen at NE ADME to discuss #QPS #bioanalysis and #DMPK capabilities. Learn more by visiting our website shorturl.at/5lEKU or email info@qps.com.

Will Giorgi Kobidze win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hTWP_0 #BRSA2026

A lot of scientific work is slower than it should be for a surprisingly simple reason: powerful tools still need people to move the work between them. In bioanalysis, teams already have tools they trust. SCIEX OS, Skyline, Analyst, Thermo, Waters, internal scripts. They are often very good at the specific jobs they were built for. The problem becomes obvious when you zoom out from any one tool and look at the whole workflow: a file gets moved from one place to another. A folder has to be prepared in the right format. A method has to be selected. A run has to be configured. Outputs need to be checked, copied, reviewed, and turned into something useful for the next step. None of this is exactly glamorous work. But it has to be done and done carefully. And when you watch highly trained scientists spend hours on it, you start to feel how much human attention is being spent on work that is necessary, but not very creative. We recently built an integration between ScienceMachine and SCIEX OS for one of our customers. The idea was simple: do not replace the software the team already trusts. Instead, make it part of a larger workflow that ScienceMachine can help orchestrate. Read the full technical write-up in the comments 📷 ScienceMachine can now reach into a real customer environment, work with SCIEX OS in the place it already runs, and turn a manual desktop workflow into a secure, repeatable step in a larger scientific process. The best part is that every integration like this compounds. Once ScienceMachine can work with one important tool in the workflow, it becomes easier to connect the next one, and then the next one, until more of the scientific process starts to feel continuous instead of fragmented.

An update on the latest M&A deals impacting bioanalysis! The most recent biopharma partnerships and acquisitions reflect several key industry trends: ➡️The race to develop innovative cancer treatments through advanced modalities like antibody-drug conjugates (ADCs) and multi-specific antibodies. ➡️Expansion into underserved therapeutic areas including rare diseases and women’s health. ➡️The growing importance of cross-border collaborations that combine Eastern discovery capabilities with Western commercial scale. In this article, we review some of the latest deals impacting pharma and biotech 👉 hubs.ly/Q04kD6sW0

Johnson & JohnsonによるFirefly Bioの$1B買収 Firefly、近所ですしちょっとしたコネクションもあったのですが、このニュースは驚きでした。少し落ち着いてきてしまった感のあったDACですが、FireflyはDACど真ん中ですね。 特に何かと話題のKRAS変異固形がんに対して、pan-KRAS degraderを送達するアプローチは興味深いですね。 ただしDACは、従来型ADCのpayloadをdegraderに置き換えるだけでは成立しません。抗原選択、internalization、linker切断、細胞内release、標的タンパク質への結合、E3 ligaseへのrecruitment、十分な細胞内濃度の確保がすべて必要になります。 成立すれば、低分子degrader単独では難しい組織選択性や安全域を、抗体送達で補える可能性があります。一方で、CMC、bioanalysis、DAR制御、released degraderの定量、細胞内pharmacologyはADC以上に複雑になるかもしれません。 DACはまだ臨床的に確立したmodalityではありませんが、今回の買収は、大手製薬が次世代ADC周辺技術としてかなり真剣に見ていることを示す事例だと思います。

Will Ethan Sanford win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hSZdn0 #BRSA2026

📢 New Meeting Report! An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assays. Read more about the article: hubs.ly/Q04k75fc0

Why choose ASI? Over 30 years of analytical expertise, advanced scientific capability and clear interpretation across forensic toxicology, bioanalysis and analytical science. 🔗 Find out more: eu1.hubs.ly/H0v-BKM0 #Toxicology #Bioanalysis #ForensicScience

Will Richa Pandey win your support? Check out the finalists’ profiles and help us choose the 2026 bioanalysis rising star! 🏆 hubs.ly/Q04hSGQ10 #BRSA2026

約1年間、毎日ALL 1 ∞で波動調整してる方のCHI Fractal Bioanalysis(医療機器)による測定結果です。 凄いと思いませんか！（第2弾 経絡図） raremo.tokyo #腸活習慣Daizen #ハイドリッチ #ハイドロバス #水溶性plasmMDケイ素 #レアモショップ #株式会社レアシード

約1年間、毎日ALL 1 ∞で波動調整してる方のCHI Fractal Bioanalysis(医療機器)による測定結果です。 凄いと思いませんか！ raremo.tokyo #腸活習慣Daizen #ハイドリッチ #ハイドロバス #水溶性plasmMDケイ素 #オーガニックボタニカルクリーム #レアモショップ #株式会社レアシード

Timothy Snow and Ragu Ramanathan will share LC-MS/HRMS characterization of ligands and siRNA metabolites in 2 Posters at #ASMS 2026. Learn more about QPS #bioanalysis and #DMPK, visit https: //www.qps.com/bioanalysis/, qps.com/service/dmpk, or email info@qps.com.